These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Williams K. Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753 [Abstract] [Full Text] [Related]
5. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Avenet P, Léonardon J, Besnard F, Graham D, Depoortere H, Scatton B. Neurosci Lett; 1997 Feb 21; 223(2):133-6. PubMed ID: 9089691 [Abstract] [Full Text] [Related]
14. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Avenet P, Léonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ, Scatton B. Eur J Pharmacol; 1996 Jan 25; 296(2):209-13. PubMed ID: 8838458 [Abstract] [Full Text] [Related]
17. Functional expression of recombinant N-methyl-D-aspartate receptors in the yeast Saccharomyces cerevisiae--localization and pharmacological characterization. Li Z, Becker J, Noe CR. Eur J Biochem; 1998 Mar 15; 252(3):391-9. PubMed ID: 9546654 [Abstract] [Full Text] [Related]
20. Subunit-specific effects of poricoic acid A on NMDA receptors. Lee J, Kim C, Yeom HD, Nguyen KVA, Eom S, Lee S, Jung JH, Lee JH, Kim SH, Kim IK, Lee JH. Pharmacol Rep; 2020 Apr 15; 72(2):472-480. PubMed ID: 32048268 [Abstract] [Full Text] [Related] Page: [Next] [New Search]